Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 31 to 45 of 75 results for pulmonary embolism

  1. Balloon angioplasty of pulmonary vein stenosis in infants (HTG46)

    Evidence-based recommendations on balloon angioplasty of pulmonary vein stenosis in infants. This involves involves inflating a balloon in the narrow section of the pulmonary vein to widen the area so blood can flow through more easily.

    HealthTech guidance
    Published
    28 July 2004
    View recommendations

    Sections for HTG46

  2. Ultrasound-guided foam sclerotherapy for varicose veins (HTG301)

    Evidence-based recommendations on ultrasound guided foam sclerotherapy for varicose veins. This involves mixing a chemical with air or another gas to produce a foam, which is injected into the affected vein using ultrasound imaging to monitor its progress.

    HealthTech guidance
    Published
    23 February 2013
    View recommendations

    Sections for HTG301

  3. Minimally invasive total hip replacement (HTG236)

    Evidence-based recommendations on minimally invasive total hip replacement. This involves replacing the damaged hip joint (the top part of the upper leg bone and the socket in the hip bone that it fits into) with an artificial one.

    HealthTech guidance
    Published
    27 October 2010
    View recommendations

    Sections for HTG236

  4. Sunitinib for the treatment of gastrointestinal stromal tumours (TA179)

    Evidence-based recommendations on sunitinib (Sutent) for treating gastrointestinal stromal tumours in adults.

    Technology appraisal guidance
    Published
    23 September 2009
    View recommendations

    Sections for TA179

  5. Forward view - our priority topics

    Our forward view highlights the topics we will prioritise in the coming year.

  6. Andexanet alfa for reversing anticoagulation from apixaban or rivaroxaban (TA697)

    Evidence-based recommendations on andexanet alfa (Ondexxya) for reversing anticoagulation form apixaban or rivaroxaban in adults with life-threatening or uncontrolled bleeding.

    Technology appraisal guidance
    Last updated
    15 January 2025
    View recommendations

    Sections for TA697

  7. Research into the long-term treatment effects of rivaroxaban is needed.

    guidance details Comes from guidance Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism Number

    Research recommendation
    Published
    9 June 2015

  8. Further research on the clinical effectiveness of rivaroxaban compared with low molecular weight heparin (LMWH) in patients with active cancer should be conducted.

    vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism Number TA261 Date issued July 2012 Other

    Research recommendation
    Published
    9 June 2015

  9. Further research should be in the form of randomised controlled trials or registries. It should report:

    guidance Percutaneous thrombectomy for intermediate-risk or high-risk pulmonary embolism Number IPG778 Date issued November 2023

    Research recommendation
    Published
    11 January 2024

  10. Duration of prophylaxis for elective total hip replacement surgery:- What is the clinical and cost effectiveness of standard versus extended duration pharmacological prophylaxis for preventing VTE in people undergoing elective total hip replacement surgery?

    16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism Number NG89 Date issued March 2018 Other

    Research recommendation
    Published
    15 November 2018

  11. Laparoscopic liver resection (HTG83)

    Evidence-based recommendations on laparoscopic liver resection. This involves making small incisions (keyhole surgery) to remove the parts of the liver that are benign or cancerous.

    HealthTech guidance
    Published
    27 July 2005
    View recommendations

    Sections for HTG83

  12. Effects of HRT on venous thromboembolism risk:- How does the preparation of HRT affect the risk of venous thromboembolism (VTE)?

    important:- An increase in the risk of VTE (deep vein thrombosis [DVT] or pulmonary embolism [PE]) is a significant side effect of HRT,...

    Research recommendation
    Published
    11 December 2015

  13. COVID-19 rapid guideline: managing COVID-19 (NG191)

    This guideline covers managing COVID-19 in babies, children, young people and adults in community and hospital settings. It includes recommendations on communication, assessment, therapeutics for COVID-19, non-invasive respiratory support, preventing and managing acute complications, and identifying and managing co-infections.

    COVID-19 rapid guideline
    Last updated
    1 May 2025

    Sections for NG191

  14. Aspirin prophylaxis for people with fragility fractures of the pelvis, hip or proximal femur:- What is the clinical and cost effectiveness of aspirin alone versus other pharmacological and/or mechanical prophylaxis strategies (alone or in combination) for people with fragility fractures of the pelvis, hip or proximal femur?

    16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism Number NG89 Date issued March 2018 Other

    Research recommendation
    Published
    15 November 2018

  15. Apixaban for preventing venous thromboembolism after hip or knee replacement surgery (TA245)

    Evidence-based recommendations on apixaban (Eliquis) for preventing venous thromboembolism after hip or knee replacement in adults.

    Technology appraisal guidance
    Published
    25 January 2012
    View recommendations

    Sections for TA245